ropinirole IR / Generic mfg. |
NCT00363857: A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome |
|
|
| Completed | 3 | 360 | US | Ropinirole | GlaxoSmithKline | Restless Legs Syndrome (RLS), Restless Legs Syndrome | 05/04 | 05/04 | | |
NCT00225862: A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) |
|
|
| Completed | 3 | 140 | US | ropinirole | GlaxoSmithKline | Restless Legs Syndrome | | 12/05 | | |
NCT00197080: Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome |
|
|
| Completed | 3 | 380 | US, Canada | Ropinirole Extended Release (XR) | GlaxoSmithKline | Restless Legs Syndrome | | 01/06 | | |
NCT00314860: RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole |
|
|
| Completed | 3 | 568 | US, Europe, RoW | ropinirole Extended Release (XR) | GlaxoSmithKline | Restless Legs Syndrome, Restless Legs Syndrome (RLS) | 12/06 | 12/06 | | |
NCT00355641: Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome |
|
|
| Completed | 3 | 450 | US, Canada | Ropinirole Extended Release (XR) | GlaxoSmithKline | Restless Legs Syndrome | 10/07 | 10/07 | | |
NCT00357097: The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome |
|
|
| Completed | 3 | 240 | Europe | Ropinirole | GlaxoSmithKline | Restless Legs Syndrome, Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) | 12/07 | 12/07 | | |
| Completed | 3 | 300 | Europe | Lisuride, Ropinirole, Placebo | Axxonis Pharma AG | Restless Legs Syndrome | | | | |